Abstract:We transfected a recombinant plasmid that co-expressed swine ubiquitin and a codon optimized GP5 encoding-gene of porcine reproductive and respiratory syndrome virus (PRRSV), designated pCA-U-optiGP5, as well as the plasmid pCA-optiGP5 encoding codon optimized GP5, and the plasmid pCA-GP5 expressing wild-type pGP5 into 293T cells. Expression of GP5 was measured by indirect immunofluorescence (IIF) assay and Western blot and found to be considerably higher in response to pCA-U-optiGP5 than the wild-type vector. GP5 protein was rapidly degraded in pCA-U-optiGP5-transfected 293T cells. The proteasome inhibitor, MG-132, however, successfully inhibited degradation. Immunogenicity of the three constructs was examined by measuring GP5-specific antibody production, lymphocyte proliferation, cytotoxic T lymphocyte (CTL) responses, and cytokine secretion in intramuscularly immunized pigs. Three weeks after the last inoculation, all animals were challenged intranasally with 2-ml 10(5)TCID(50)/ml PRRSV CH-1a. DNA immunization with pCA-optiGP5 produced a higher level of GP5-specific antibody than immunization with pCA-GP5, and the humoral response remained undetectable in the pCA-U-optiGP5 group. However, the fusion DNA had a significantly enhanced stimulation index (SI) and induced a stronger Th1 type cellular immune response than the single gene DNA, suggesting that ubiquitin conjugation improved the cellular but not the humoral immune response. Four of six pigs in the pCA-U-optiGP5 group, three of six in the pCA-optiGP5 group, and two of six in the pCA-GP5 group were devoid of visible pathological changes that were present in other vaccinated and control animals after challenge. Viral replication and distribution in the blood and tissues was lower in the pCA-U-optiGP5 vaccinated group than the other groups, suggesting that codon optimization, along with the development of rapidly processed antigen, represents a novel strategy to increase the immune efficacy of DNA vaccines against PRRSV.

A Recombinant Plasmid Co-Expressing Swine Ubiquitin and the GP5 Encoding-Gene of Porcine Reproductive and Respiratory Syndrome Virus Induces Protective Immunity in Piglets.

Construction of Recombinant Plasmid Co-Expressing Swine Ubiquitin Gene with GP5 Gene of Porcine Reproductive and Respiratory Virus and Analysis of Its Immunogenicity in Mice

Porcine GPX1 enhances GP5-based DNA vaccination against porcine reproductive and respiratory syndrome virus

Immunization in Pigs Vaccined with DNA Encoding PRRSV GP5

Immunogenicity of the highly pathogenic porcine reproductive and respiratory syndrome virus GP5 protein encoded by a synthetic ORF5 gene

Effects of DNA recombinant plasmids against porcine reproductive and respiratory syndrome on immunity in pigs

Enhanced immunogenicity of the modified GP5 of porcine reproductive and respiratory syndrome virus

Study on Immunological Responses to Porcine Reproductive and Respiratory Syndrome Virus DNA Vaccines Co-expressing Modified GP5 (gp5m) and M Proteins

Immunogenicity of the Glycoprotein 5 Truncated Trans-Membrane Regions of Porcine Reproductive and Respiratory Syndrome Virus

Immunogenicity and Protective Efficacy of Recombinant Pseudorabies Virus Expressing the Two Major Membrane-Associated Proteins of Porcine Reproductive and Respiratory Syndrome Virus

Immunogenicity of Envelope Gp5 Protein Displayed on Baculovirus and Protective Efficacy Against Virulent Porcine Reproductive and Respiratory Syndrome Virus Challenge in Piglets

DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity.

Immune Responses Induced by DNA Vaccination of Ubiquitin-Conjugated GP5 Protein Gene of Porcine Respiratory and Reproductive Syndrome Virus

Vaccination of Mice with ORF5 Plasmid DNA of PRRSV; Enhanced Effects by Co-Immunizing with Porcine IL-15.

Immunological evaluation of recombination PRRSV GP3 and GP5 DNA vaccines <i>in vivo</i>

Immune Responses in Pigs Induced by Recombinant DNA Vaccine Co-Expressing Swine IL-18 and Membrane Protein of Porcine Reproductive and Respiratory Syndrome Virus.

Immunological evaluation of recombination PRRSV GP3 and GP5 DNA vaccines in vivo

GM-CSF fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus increased the immune responses and protective efficacy against virulent PRRSV challenge.

Immune responses in pigs induced by recombinant canine adenovirus 2 expressing the glycoprotein 5 of porcine reproductive and respiratory syndrome virus

Enhanced Humoral Immune Response of DNA Vaccine Composing a Modified ORF5 Gene of Porcine Reproductive and Respiratory Syndrome Virus

Construction and Immunogenicity of Pseudotype Baculovirus Expressing GP5 and M Protein of Porcine Reproductive and Respiratory Syndrome Virus